Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
CC transcript
Credit agrmnt [a]
Appointed director
Inv. presentation
Quarterly results
Acq. announced
Director departure

Bausch Health Companies Inc. (BHC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2023 RESULTS, OTHER KEY UPDATES FROM THE QUARTER, AND RAISES FULL-YEAR 2023 REVENUE OUTLOOK"
08/09/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
11/02/2021 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD-QUARTER 2021 RESULTS"
08/03/2021 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES SECOND-QUARTER 2021 RESULTS",
"BAUSCH HEALTH ANNOUNCES PLANS TO PURSUE AN INITIAL PUBLIC OFFERING OF SOLTA MEDICAL"
11/03/2020 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD-QUARTER 2020 RESULTS"
08/06/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
11/04/2019 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD-QUARTER 2019 RESULTS AND RAISES FULL-YEAR REVENUE AND ADJUSTED EBITDA GUIDANCE RANGES"
08/06/2019 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES SECOND-QUARTER 2019 RESULTS AND RAISES FULL-YEAR GUIDANCE"
05/06/2019 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES FIRST-QUARTER 2019 RESULTS AND RAISES FULL YEAR GUIDANCE"
11/06/2018 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD-QUARTER 2018 RESULTS"
08/07/2018 8-K Quarterly results
Docs: "BAUSCH HEALTH COMPANIES INC. ANNOUNCES SECOND-QUARTER 2018 RESULTS"
05/08/2018 8-K Quarterly results
Docs: "VALEANT ANNOUNCES FIRST-QUARTER 2018 RESULTS AND RAISES REVENUE AND ADJUSTED EBITDA GUIDANCE",
"VALEANT WILL BECOME BAUSCH HEALTH COMPANIES INC."
11/07/2017 8-K Quarterly results
Docs: "VALEANT ANNOUNCES THIRD-QUARTER 2017 RESULTS"
08/08/2017 8-K Quarterly results
Docs: "VALEANT ANNOUNCES SECOND-QUARTER 2017 RESULTS"
05/09/2017 8-K Form 8-K - Current report
11/08/2016 8-K Quarterly results
Docs: "VALEANT REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS"
08/09/2016 8-K Form 8-K - Current report
06/07/2016 8-K Form 8-K - Current report
10/19/2015 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS 2015 Third Quarter Results"
07/23/2015 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS 2015 Second Quarter Results"
04/29/2015 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS FIRST QUARTER 2015 FINANCIAL RESULTS SEPERATELY, VALEANT ANNOUNCES CFO SUCCESSION PLAN AND ADDITIONAL EXECUTIVE APPOINTMENT 2015 First Quarter Results"
02/23/2015 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2014 FINANCIAL RESULTS PROVIDING FIRST QUARTER 2015 CASH EPS GUIDANCE DENDREON ACQUISITION EXPECTED TO CLOSE FEBRUARY 23, 2015 VALEANT TO ACQUIRE SALIX PHARMACEUTICALS FOR $158.00 PER SHARE IN CASH FULL YEAR 2015 GUIDANCE, REFLECTING SALIX AND DENDREON, AS WELL AS EXPECTED BUSINESS OUTPERFORMANCE, WILL BE UPDATED ON FIRST QUARTER 2015 EARNINGS CALL VALEANT TO HOLD CONFERENCE CALL TO DISCUSS SALIX TRANSACTION AND FOURTH QUARTER AND FULL YEAR 2014 FINANCIAL RESULTS AT 8:00 AM ET ON MONDAY, FEBRUARY 23 2014 Fourth Quarter Results"
10/20/2014 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS THIRD QUARTER 2014 FINANCIAL RESULTS"
07/31/2014 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS"
05/08/2014 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS",
"Letter of Resignation of G. Mason Morfit"
02/27/2014 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS Fourth Quarter 2013"
10/31/2013 8-K Form 8-K - Current report
08/07/2013 8-K Form 8-K - Current report
05/02/2013 8-K Form 8-K - Current report
02/28/2013 8-K Quarterly results
Docs: "VALEANT PHARMACEUTICALS REPORTS 2012 FOURTH QUARTER FINANCIAL RESULTS Fourth Quarter 2012"
11/02/2012 8-K Form 8-K - Current report
08/02/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy